Kuru Gözün Anksiyete ve Depresyon ile İlişkisi

Year 2020, Volume: 17 Issue: 3, 366 - 371, 25.12.2020

Müge Fırat

https://doi.org/10.35440/hutfd.672944

Abstract

Amaç: Bu çalışmanın amacı, kuru göz sendromunda anksiyeteye ve depresyona eğilimin daha önce psikiyatrik tanı veya tedavi almamış hastalarda değerlendirmektir.
Materyal ve metod: 32 kuru göz hastası ve 31 kontrol grubu hastasının dahil edildiği çalışmada, tüm katılımcılara Schirmer ve Gözyaşı Kırılma Zamanı (GKZ) testleri, Oküler Yüzey Hastalığı İndeksi (OSDI) uygulandı ve psikolojik değerlendirmeleri için Beck Anksiyete Ölçeği (BAÖ), Beck Depresyon Ölçeği (BDÖ) kullanıldı.
Bulgular: Her iki grup arasında schirmer, GKZ, OSDI değerleri arasında anlamlı fark vardır (p<0,001). BDÖ sonuçlarına göre hasta grubunun %53,1’i depresyon olan gruptaydı. Kontrol grubunda ise %35,5’i depresyon olan gruptaydı. Depresyon pozitif hasta sayısı kontrol grubunda daha düşük olmakla birlikte anlamlı farklılık saptanmadı (p> 0,05). BAÖ sonuçlarına göre hasta grubunda anksiyete olan %71,9 hasta bulunurken kontrol grubunda ise %41,9 hasta vardı. Gruplarda anksiyete varlığına göre istatistiksel anlamlı fark saptanmıştır (p<0,05). Anksiyetesi olmayan hasta sayısı, kontrol grubunda hasta grubunun iki katı kadardır. Kontrol grubunda şiddetli anksiyetesi olanlar (%3,2) ile çalışma grubundaki şiddetli anksiyetesi olanlar (%21,9) arasında anlamlı fark saptandı (p<0,05).
Sonuç: Bu çalışmada kuru göz sendromunun özellikle anksiyete ile ilişki gösterdiği sonucuna varılmıştır. Kuru göz sendromu tedavi uyumunda ve psikiyatri kliniklerindeki tedavi uygulamalarında bu ilişkinin göz önünde bulundurulması gerekmektedir.

Anahtar Kelimeler: Kuru Göz, Depresyon, Anksiyete

Keywords

kuru göz, anksiyete, depresyon

Supporting Institution

Tokat İl Sağlık Müdürlüğü

Project Number

04/01/2019-01-03

Thanks

Dr. Sedef Öner

The Relationship of Dry Eye with Anxiety And Depression

Abstract

Background: The aim of this study was to evaluate the tendercy to anxiety and depression in dry eye disease patients who had not previously received psychiatric diagnose or treatment.
Materials and Methods: The study included 32 dry eye, 31 control group patients. Schirmer, Tear Break Up Time (TBUT) and The Ocular Surface Disease Index (OSDI) were performed. Beck Anxiety Inventory and Beck Depression Inventory were used for psychological evaluation.
Results: Schirmer test, TBUT, OSDI values were significantly different in both groups (p <0.001). In the patient group 53.1% had positive depression score while 35.5% had positive depression score in the control group. Although the number of patients with depression was lower in the control group, there was no significant difference between the patient group (p> 0.05). According to positive anxiety results, there was a statistically significant difference between the patient group (71.9% vs 41.9%) (p <0.05). The patients with severe anxiety were significally lower in the control group (3.2% vs 21.9%) (p <0.05).
Conclusion: In this study, dry eye syndrome was associated with anxiety. This relationship needs to be taken into consideration in compliance with dry eye treatment and treatment practices in psychiatry clinics

Key words: Dry eye, Depression, Anxiety

Project Number

04/01/2019-01-03

References

• 1. Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II Definition and Classification Report. Ocul Surf. 2017;15:276-83.
• 2. Mertzanis P, Abetz L, Rajagopalan K, Espindle D, Chalmers R, Snyder C et al. The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample. Invest Ophthalmol Vis Sci. 2005;46:46–50.
• 3. Miljanovic B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007;143:409–415.
• 4. Chen W, Li J, Zheng Q. Prevalence and Risk Factors of Dry Eye Disease Among a Hospital-based Population. Invest Ophthalmol Vis Sci. 2013;54:935.
• 5. Li M, Gong L, Chapin WJ, Zhu M. Assessment of vision-related quality of life in dry eye patients. Invest Ophthalmol Vis Sci. 2012;53:5722-7.
• 6. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118:615–621.
• 7. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571.
• 8. Hisli N. Beck Depresyon Envanterinin geçerliği üzerine bir çalışma. Psikolojie Dergisi. 1988;6:118-22.
• 9. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893-7.
• 10. Ulusoy M, Şahin N, Erkmen H. Turkish version of the Beck Anxiety Inventory: psychometric properties. J Cogn Psychother. 1998;12:28-35.
• 11. Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F. TFOS DEWS II Epidemiology Report. Ocul Surf. 2017;15:334–365.
• 12. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318–326.
• 13. Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: estimates from the Physicians’ Health Studies. Arch Ophthalmol. 2009;127:763–768.
• 14. Bron AJ, Smith JA, Calonge M. Methodologies to diagnose and monitor dry eye disease: Report of diagnostic methodology subcommittee of the international dry eye workshop. Ocul Surf. 2007;5:08-152.
• 15. Gupta A, Heigle TJ, Pflugfelder SC. Nasolacrimal stimulation of aqueous tear production. İnvest Ophthalmol Vis Sci (ARVO Suppl). 1996;37:S851.
• 16.Yiğit U, Kırık F, Evcimen Y, Ağaçhan A. Kuru Göz Sendromlu Hastalarda Gözyaşı Osmolarite Ölçümünün Schirmer Testi ve Gözyaşı Kırılma Zamanı ile İlişkisi. Bakırköy Tıp Dergisi. 2013;9:2.
• 17. Tiskaoglu NS, Yazıcı A, Karlıdere T, Sari E, Oguz EY, Musaoglu M et al. Dry Eye Disease in Patients with Newly Diagnosed Depressive Disorder. Curr Eye Res. 2016;21:1-5.
• 18. Wan K H , Chen L J , Young A L. Depression and anxiety in dry eye disease: a systematic review and meta-analysis. Eye (Lond). 2016;30:1558–1567.
• 19. Labbé A, Wang Y X, Jie Y, Baudouin C, Jonas J B, Xu L. Dry eye disease, dry eye symptoms and depression: the Beijing Eye Study. British Journal of Ophthalmology. 2013;97,1399–1403.
• 20. Mertzanis P, Abetz L, Rajagopalan K, Espindle D, Chalmers R, Synder C. The relative burden of dry eye in patients’ lives: comparisons to a US normative sample. Invest Ophthalmol Vis Sci. 2005;46:46-50.
• 21. Liyue H, Chiang P P C, Sung S C, Tong L. Dry Eye-Related Visual Blurring and Irritative Symptoms and Their Association with Depression and Anxiety in Eye Clinic Patients. Current Eye Research. 2015;41,590–599.
• 22. Li M, Gong L, Sun X, Chapin W J. Anxiety and Depression in Patients with Dry Eye Syndrome. Current Eye Research. 2010;36,1–7.
• 23. Szakáts I, Sebestyén M, Németh J, Birkás E, Purebl G. The Role of Health Anxiety and Depressive Symptoms in Dry Eye Disease. Current Eye Research. 2015;41,1044–1049.
• 24. Nepp, J. Psychosomatische Aspekte beim trockenen Auge. Der Ophthalmologe. 2016;113,111–119.
• 25. Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder S C. Interleukin-1 in the Tear Fluid and Conjunctiva of Patients with Dry-Eye Disease. İnvest Ophthalmol Vis Sci. 2001;42:2283-92.
• 26. Mrugacz M, Ostrowska L, Bryl A, Szulc A, Zelazowska-Rutkowska B, Mrugacz G. Pro-inflammatory cytokines associated with clinical severity of dry eye disease of patients with depression. Advances in Medical Sciences. 2017;62,338–344.
• 27. Moss S E. Incidence of Dry Eye in an Older Population. Archives of Ophthalmology. 2004;122,369.